Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Lipp, RW; Hammer, HF; Passath, A; Dobnig, H; Ramschak-Schwarzer, S; Stiegler, C; Leb, G; Krejs, GJ.
Primary and follow-up studies of patients with carcinoid metastases using indium 111 octreotide--rational use of Sandostatin.
Acta Med Austriaca. 1993; 20(1-2):42-44
Web of Science PubMed

 

Führende Autor*innen der Med Uni Graz
Lipp Rainer
Co-Autor*innen der Med Uni Graz
Dobnig Harald
Hammer Heinz
Krejs Günter Josef
Leb Georg
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
Carcinoids may express Somatostatin receptors. Therefore, a Somatostatin-analogue, In-111 Octreotide (OctreoScan), was used for their demonstration. A total of 6 patients who presented with radiologically verified carcinoid-metastases was examined. In order to control tumor progress, 4 of these patients were reexamined within a period of 3 to 11 months. All of the radiological findings were confirmed scintigraphically, except some small retroperitoneally located lymph nodes. The follow-up examinations of 2 patients revealed additional metastases by scintigraphy only. There were no false positive results. The results of OctreoScan scintigraphy may be used for predicting the success of receptor-specific therapies and therefore, permit the rational and efficient application of Sandostatin.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Carcinoid Tumor - drug therapy Carcinoid Tumor - radionuclide imaging Carcinoid Tumor - secondary
Female -
Follow-Up Studies -
Humans -
Indium Radioisotopes - diagnostic use
Intestinal Neoplasms - drug therapy Intestinal Neoplasms - radionuclide imaging
Liver Neoplasms - drug therapy Liver Neoplasms - radionuclide imaging Liver Neoplasms - secondary
Lymphatic Metastasis -
Male -
Middle Aged -
Octreotide - diagnostic use Octreotide - therapeutic use

Find related publications in this database (Keywords)
Carcinoids
Receptor Scintigraphy
Octreotide
© Med Uni Graz Impressum